new
   Indications for Azithromycin Tablets
502
Nov 04, 2025

Azithromycin Tablets are a representative macrolide antibiotic. With their unique pharmacokinetic properties and broad antibacterial spectrum, they hold an important position in clinical practice.

Indications for Azithromycin Tablets

Adult Indications

Acute bacterial exacerbation of chronic bronchitis (caused by Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae).

Acute bacterial sinusitis.

Community-acquired pneumonia (for patients suitable for oral treatment).

Pharyngitis/tonsillitis (as an alternative for patients who cannot tolerate first-line treatment).

Uncomplicated skin and skin structure infections.

Pediatric Indications

Acute otitis media (for children aged 6 months and older).

Community-acquired pneumonia (for children aged 6 months and older).

Pharyngitis/tonsillitis (for children aged 2 years and older).

Contraindications for Use

Patients with a known hypersensitivity to azithromycin, erythromycin, any macrolide antibiotics, or ketolide antibiotics.

Patients with a history of cholestatic jaundice/hepatic dysfunction following previous use of azithromycin.

Restricted Use Cases

Patients with cystic fibrosis.

Patients with hospital-acquired infections.

Patients with known or suspected bacteremia.

Patients requiring hospitalization.

Elderly or debilitated patients.

Specifications and Properties of Azithromycin Tablets

Tablet Specifications

250 mg tablets: Pink, modified capsule-shaped, scored film-coated tablets. One side is engraved with "PFIZER" and the other side with "306"; some batches are engraved with "Pfizer" and "ZTM250".

500 mg tablets: Pink, modified capsule-shaped, scored film-coated tablets, engraved with "Pfizer" and "ZTM500".

Oral Suspension Specifications

100 mg/5 mL suspension.

200 mg/5 mL suspension.

Storage Methods for Azithromycin Tablets

Storage Requirements for Tablets

Storage temperature range: 15°C - 30°C (59°F - 86°F).

Store in the original packaging with the seal intact.

Detailed Storage Rules for Suspension

Dry powder storage: Store at a temperature below 30°C (86°F).

Storage after reconstitution: Storage temperature range: 5°C - 30°C (41°F - 86°F).

Use the reconstituted suspension within 10 days.

Discard any remaining medicinal solution immediately after complete administration.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Dosage and Administration, Recommended Dose of Elacestrant (Orserdu)

Elacestrant (Orserdu) is a selective estrogen receptor degrader (SERD), which provides an important treatment option...

Friday, December 19th, 2025, 11:49
What Are the Indications for Elacestrant (Orserdu)?

Elacestrant (Orserdu) is a novel endocrine therapy agent that demonstrates significant value in the treatment of...

Friday, December 19th, 2025, 11:40
What Are the Purchase Channels for Elacestrant (Orserdu)?

With the advancement of medical technology, elacestrant (Orserdu), a targeted drug for breast cancer with specific...

Friday, December 19th, 2025, 11:38
Adverse Reactions of Capmatinib (Tabrecta)

Capmatinib (Tabrecta) is a highly selective MET inhibitor indicated for the treatment of patients with advanced...

Friday, December 19th, 2025, 11:35
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved